Molecular mechanisms of pancreatic cancer and potential targets of treatment

By Aho Ursula   Zhao Xia   Löhr Matthias   Andersson Roland  

Scandinavian Journal of Gastroenterology, Vol. 42, Iss. 3, 2007-01 ,pp. : 279-296

Informa Healthcare

Access to resources Recommend Favorite

Toxicity and Efficacy of Concurrent Gemcitabine and Radiotherapy for Locally Advanced Pancreatic Cancer

By Crane C.H.   Janjan N.A.   Evans D.B.   Wolff R.A.   Ballo M.T.   Milas L.   Mason K.   Charnsangavej C.   Pisters P.W.T.   Lee J.E.   Lenzi R.   Vauthey J.N.   Wong A.   Phan T.   Nguyen Q.   Abbruzzese J.L.  

International Journal of Pancreatology, Vol. 29, Iss. 1, 2001-03 ,pp. : 9-18

Humana Press, Inc

Access to resources Recommend Favorite

Effect of Low-Dose Gemcitabine on Unresectable Pancreatic Cancer in Elderly Patients

By  

Digestion, Vol. 84, Iss. 3, 2011-08 ,pp. : 230-235

Karger

Access to resources Recommend Favorite

Gastrointestinal bleeding during anti-angiogenic peptide vaccination in combination with gemcitabine for advanced pancreatic cancer

By Nagayama Hitomi  

Clinical Journal of Gastroenterology, Vol. 3, Iss. 6, 2010-12 ,pp. : 307-317

Springer Publishing Company

Access to resources Recommend Favorite

siRNA Directed Against Survivin Enhances Pancreatic Cancer Cell Gemcitabine Chemosensitivity

By Liu Wen-Song   Yan Hai-Jiao   Qin Ren-Yi   Tian Rui   Wang Min   Jiang Jian-Xin   Shen Ming   Shi Cheng-Jian  

Digestive Diseases and Sciences, Vol. 54, Iss. 1, 2009-01 ,pp. : 89-96

Springer Publishing Company

Access to resources Recommend Favorite